The use of melatonin and co-treatment with autologous or allogeneic cells as a model for control of malignant β-cell leukemia

Nir, I., Weiss, L., & Slavin, S. (1999). The use of melatonin and co-treatment with autologous or allogeneic cells as a model for control of malignant β-cell leukemia. In Advances in Experimental Medicine and Biology (Vol. 460, pp. 407–409). https://doi.org/10.1007/0-306-46814-x_48